Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-03
DOI
10.1186/s12885-020-06752-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1
- (2020) Hengyi Chen et al. Cell Death & Disease
- Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion
- (2019) Veronica S. Hughes et al. Oncotarget
- Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
- (2019) Wen-Chien Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
- (2019) Yu Shi et al. NATURE
- CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer
- (2019) Yung-Taek Ouh et al. TUMOR BIOLOGY
- Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells
- (2019) Rosita Russo et al. Cancers
- Investigational MET inhibitors to treat Renal cell carcinoma
- (2019) Lakshminarayanan Nandagopal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting IRF3 as a YAP agonist therapy against gastric cancer
- (2018) Shi Jiao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
- (2018) Xuhao Ni et al. Cancer Discovery
- Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells
- (2018) Constanze Buhrmann et al. Nutrients
- Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness
- (2017) Marit Bugge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta-analysis
- (2017) Chengjie Lin et al. LIVER INTERNATIONAL
- Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer
- (2017) Ting Wang et al. MEDICINE
- The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
- (2017) Deanna N. Edwards et al. Science Signaling
- Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
- (2017) Venkata Ramesh Dasari et al. Oncotarget
- The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
- (2017) Deanna N. Edwards et al. Science Signaling
- Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts
- (2016) Jerec W. Ricci et al. MOLECULAR CANCER THERAPEUTICS
- Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
- (2016) Yong Feng et al. OncoTargets and Therapy
- Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer
- (2016) Guangyuan Chen et al. Oncology Letters
- Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
- (2015) Denis Lane et al. BMC CANCER
- Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer
- (2015) Keith L. Knutson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
- (2015) G Hua et al. ONCOGENE
- YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
- (2015) E Ciamporcero et al. ONCOGENE
- Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells
- (2015) Takuya Nakamura et al. Oncotarget
- Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer
- (2014) Masahiro Tsujiura et al. PLoS One
- Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
- (2014) T. Mariya et al. Cancer Immunology Research
- Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts
- (2013) Tat-San Lau et al. JOURNAL OF PATHOLOGY
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma
- (2013) Marina Bagnoli et al. Biomed Research International
- First-line Chemotherapy in Epithelial Ovarian Cancer
- (2012) MICHAEL A. BOOKMAN CLINICAL OBSTETRICS AND GYNECOLOGY
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
- (2012) Radosław Januchowski et al. Biomed Research International
- Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer
- (2010) I. Rizvi et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
- (2010) I. Lian et al. GENES & DEVELOPMENT
- Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
- (2009) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now